Efficacy of Subcutaneous Injection of Etanercept for Moderate and Severe Knee Osteoarthritis
Status:
Unknown status
Trial end date:
2017-08-01
Target enrollment:
Participant gender:
Summary
Primary aim: evaluate efficacy of subcutaneous injection of etanercept for moderate and
severe knee osteoarthritis.
Second aim: investigate the potentiality of serum cytokines (TNF-α, Interleukin 1-α (IL1-α),
IL1-β, matrix metalloproteinases1 (MMP1), MMP13) to predict the response of subcutaneous
injection of etanercept for moderate and severe knee osteoarthritis.
Phase:
N/A
Details
Lead Sponsor:
First Affiliated Hospital of Harbin Medical University